+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cusp thrombosis of a self-expandable sutureless aortic valve treated by valve-in-valve transcatheter aortic valve implantation procedure: case report

Cusp thrombosis of a self-expandable sutureless aortic valve treated by valve-in-valve transcatheter aortic valve implantation procedure: case report

European Heart Journal. Case Reports 2(4): Yty117

Surgical implantation rates of bioprosthetic valves, especially the use of sutureless or rapid deployment valves, as well as the advent of transcatheter valve implantation (TAVR) have increased during the last decades mainly due to their excellent haemodynamic and clinical results. One common characteristic of all bioprosthetic types of surgical aortic valve replacement (SAVR) and TAVR is the risk of early degeneration, which leads to valve-dysfunction and is associated with higher rates of valve reinterventions. Recent studies have demonstrated that cusp thrombosis may play a role in early valve dysfunction. This case report is, to our knowledge, the first documentation on a successful treatment of early aortic valve (AV) degeneration of a sutureless AV thrombosis with a valve-in-valve (ViV) TAVR implantation. A 77 years old woman was re-evaluated from the heart-team, which considered the following characteristics: severe impairment of mobility and frailty with an STS-score of 10.01% and a EuroSCORE II of 6.9%. Due to the high surgical risk for SAVR, we decided to perform a ViV-TAVR using a balloonexpandable bioprosthesis. The procedure was performed via transfemoral access under general anaesthesia using a 23 mm Edwards-Sapien 3 bioprosthesis without balloon-valvuloplasty and with nominal-volume dilation under rapid-pacing. The differentiation of bioprosthesis valve thrombosis, and hypoattenuating leaflet thickening vs. structural valve degeneration can be difficult, and a multimodality imaging approach, comprising trans-thoracic echocardiogram, transoesophageal echocardiography and computed tomography, useful. These investigations are very important to decide the right strategy of surgical valve replacement vs. TAVR.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 066722484

Download citation: RISBibTeXText

PMID: 31020193

DOI: 10.1093/ehjcr/yty117

Related references

The first transcatheter valve-in-valve implantation of a self-expandable valve for the treatment of a degenerated sutureless aortic bioprosthesis. Hellenic Journal of Cardiology 2019:, 2019

Early Hemodynamic Results In Patients With Small Aortic Annulus Undergoing Surgical Sutureless Aortic Valve Replacement (Perceval) And Balloon-Expandable Transcatheter Aortic Valve Implantation. Canadian Journal of Cardiology 32(10): S305-S306, 2016

Failing transcatheter aortic valve treated by transcatheter aortic valve in transcatheter aortic valve (TAV-in-TAV) implantation: valve safety versus valve durability. Eurointervention 10(8): 1000, 2014

Prosthetic Valve Endocarditis after Transcatheter Aortic Valve Implantation Complicated by Paravalvular Abscess and Treated by Pericardial Patches and Sutureless Valve Replacement. Heart Surgery Forum 22(2): E155, 2019

Minimally invasive aortic valve replacement with a sutureless valve through a right anterior mini-thoracotomy versus transcatheter aortic valve implantation in high-risk patients. European Journal of Cardio-Thoracic Surgery 49(3): 960-965, 2016

Minimally invasive aortic valve replacement with sutureless valve is the appropriate treatment option for high-risk patients and the "real alternative" to transcatheter aortic valve implantation. Journal of Thoracic and Cardiovascular Surgery 151(3): 610-613, 2016

Transcatheter aortic valve-in-valve implantation and sutureless aortic valve replacement: two strategies for one goal in redo patients. Minerva Cardioangiologica 64(6): 581-585, 2016

Patient-Prosthesis Mismatch: Clinical And Haemodynamic Outcome Of Redo Patients Undergoing Transcatheter Aortic Valve-In-Valve Implantation Versus Sutureless Aortic Valve Replacement. Interactive CardioVascular and Thoracic Surgery 19(Suppl 1): S16-S17, 2014

Transapical transcatheter aortic valve implantation in a complex aortic surgical patient: A case involving the youngest valve-in-valve implantation with a 29 mm transcather valve. Experimental and Clinical Cardiology 17(4): 251-253, 2012

Percutaneous transcatheter valve-in-valve implantation with the balloon-expandable valve for the treatment of a dysfunctional tricuspid bioprosthetic valve: a pediatric case report. Journal of Invasive Cardiology 25(6): 310-312, 2013

Transcatheter valve-in-valve implantation in a patient with a degenerative sutureless aortic bioprosthesis: case report and literature review. Giornale Italiano di Cardiologia 18(12 Suppl 1): 18s, 2017

Comparative performance of transcatheter aortic valve-in-valve implantation versus conventional surgical redo aortic valve replacement in patients with degenerated aortic valve bioprostheses: systematic review and meta-analysis. European Journal of Cardio-Thoracic Surgery 53(3): 495-504, 2018

Valve-in-valve transcatheter aortic valve implantation into a novel, sutureless bioprosthesis: technical considerations. Eurointervention 13(16): 1902-1903, 2018

In the era of the valve-in-valve: is transcatheter aortic valve implantation (TAVI) in sutureless valves feasible?. Annals of Cardiothoracic Surgery 4(2): 214-217, 2015

Transfemoral transcatheter aortic valve implantation using a self-expandable valve in a patient with an aortobiiliac bypass graft: a case report. Journal of Thoracic Disease 10(10): E744, 2018